Skip to main content
Top
Gepubliceerd in: Pallium 1/2010

01-02-2010 | HET SYMPTOOM

Longkanker en overvloedige slijmproductie

Gepubliceerd in: Pallium | Uitgave 1/2010

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Overvloedige bronchiale slijmproductie (bronchorrhoea) komt in de palliatieve zorg nogal eens voor bij patiënten met adenocarcinomen van de longen. Het kan leiden tot infecties of ernstige benauwdheid. Medicamenten als opioïden of benzodiazepinen kunnen de situatie verergeren. Toch zijn er effectieve behandelingen mogelijk.
Literatuur
1.
2.
go back to reference Bouyahia O,Essadem L,Matoussi N,et al. Etiology and outcome of bronchiectasis in children: a study of 41 patients. Tunis Med 2008;86:996-9.PubMed Bouyahia O,Essadem L,Matoussi N,et al. Etiology and outcome of bronchiectasis in children: a study of 41 patients. Tunis Med 2008;86:996-9.PubMed
3.
go back to reference Shimura S,Sasaki T,Sasaki H,Takishima T. Chemical properties of bronchorrhea sputum in bronchial asthma. Chest 1988;94:1211-5.CrossRef Shimura S,Sasaki T,Sasaki H,Takishima T. Chemical properties of bronchorrhea sputum in bronchial asthma. Chest 1988;94:1211-5.CrossRef
4.
go back to reference So SY,Lam WK,Sham MK. Bronchorrhea. A presenting feature of active endobronchial tuberculosis. Chest 1983;84:635-6.PubMedCrossRef So SY,Lam WK,Sham MK. Bronchorrhea. A presenting feature of active endobronchial tuberculosis. Chest 1983;84:635-6.PubMedCrossRef
5.
go back to reference Lee KS, Kim Y, Han J, Ko EJ, Park CK, Primack SL. Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings. Radiographics 1997;17:1345-57.PubMed Lee KS, Kim Y, Han J, Ko EJ, Park CK, Primack SL. Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings. Radiographics 1997;17:1345-57.PubMed
6.
go back to reference Hidaka N, Nagao K. Bronchioloalveolar carcinoma accompanied by severe bronchorrhea. Chest 1996;110:281-2.PubMedCrossRef Hidaka N, Nagao K. Bronchioloalveolar carcinoma accompanied by severe bronchorrhea. Chest 1996;110:281-2.PubMedCrossRef
7.
go back to reference Bonneau A. Cough in the palliative care setting. Can Fam Physician 2009;55:600-2.PubMed Bonneau A. Cough in the palliative care setting. Can Fam Physician 2009;55:600-2.PubMed
8.
go back to reference Hasani A, Spiteri MA, Pavia D, Lopez-Vidriero MT, Agnew JE, Clarke SW. Effect of temazepam on tracheobronchial mucus clearance. Thorax 1992;47:298-300.PubMedCrossRef Hasani A, Spiteri MA, Pavia D, Lopez-Vidriero MT, Agnew JE, Clarke SW. Effect of temazepam on tracheobronchial mucus clearance. Thorax 1992;47:298-300.PubMedCrossRef
9.
go back to reference Nakajima T, Terashima T, Nishida J, Onoda M, Koide O. Treatment of bronchorrhea by corticosteroids in a case of bronchioloalveolar carcinoma producing CA19-9. Intern Med 2002;41:225-8.PubMedCrossRef Nakajima T, Terashima T, Nishida J, Onoda M, Koide O. Treatment of bronchorrhea by corticosteroids in a case of bronchioloalveolar carcinoma producing CA19-9. Intern Med 2002;41:225-8.PubMedCrossRef
10.
go back to reference Tamaoki J, Kohri K, Isono K, Nagai A. Inhaled indomethacin in bronchorrhea in bronchioloalveolar carcinoma: role of cyclooxygenase. Chest 2000;117:1213-4.PubMedCrossRef Tamaoki J, Kohri K, Isono K, Nagai A. Inhaled indomethacin in bronchorrhea in bronchioloalveolar carcinoma: role of cyclooxygenase. Chest 2000;117:1213-4.PubMedCrossRef
11.
go back to reference Suga T, Sugiyama Y, Fujii T, Kitamura S. Bronchioloalveolar carcinoma with bronchorrhoea treated with erythromycin. Eur Respir J 1994;7:2249-51.CrossRef Suga T, Sugiyama Y, Fujii T, Kitamura S. Bronchioloalveolar carcinoma with bronchorrhoea treated with erythromycin. Eur Respir J 1994;7:2249-51.CrossRef
12.
go back to reference Milton DT, Kris MG, Gomez JE, Feinstein MB. Prompt control of bronchorrhea in patients with bronchioloalveolar carcinoma treated with gefitinib (Iressa). Support Care Cancer 2005;13:70-2.PubMedCrossRef Milton DT, Kris MG, Gomez JE, Feinstein MB. Prompt control of bronchorrhea in patients with bronchioloalveolar carcinoma treated with gefitinib (Iressa). Support Care Cancer 2005;13:70-2.PubMedCrossRef
13.
go back to reference Kitazaki T, Soda H, Doi S, Nakano H, Nakamura Y, Kohno S. Gefitinib inhibits MUC5AC synthesis in mucin-secreting non-small cell lung cancer cells.Lung Cancer 2005;50:19-24.PubMedCrossRef Kitazaki T, Soda H, Doi S, Nakano H, Nakamura Y, Kohno S. Gefitinib inhibits MUC5AC synthesis in mucin-secreting non-small cell lung cancer cells.Lung Cancer 2005;50:19-24.PubMedCrossRef
14.
go back to reference Kitazaki T, Fukuda M, Soda H, Kohno S. Novel effects of gefitinib on mucin production in bronchioloalveolar carcinoma;two case reports. Lung Cancer 2005;49:125-8.PubMedCrossRef Kitazaki T, Fukuda M, Soda H, Kohno S. Novel effects of gefitinib on mucin production in bronchioloalveolar carcinoma;two case reports. Lung Cancer 2005;49:125-8.PubMedCrossRef
15.
go back to reference Hudson E,Lester JF,Attanoos RL,Linnane SJ,Byrne A. Successful treatment of bronchorrhea with octreotide in a patient with adenocarcinoma of the lung. J Pain Symptom Manage 2006;32:200-2.PubMedCrossRef Hudson E,Lester JF,Attanoos RL,Linnane SJ,Byrne A. Successful treatment of bronchorrhea with octreotide in a patient with adenocarcinoma of the lung. J Pain Symptom Manage 2006;32:200-2.PubMedCrossRef
16.
go back to reference Matsushita K, Okabayashi Y, Hasegawa H, et al. In vitro inhibitory effect of somatostatin on secretin action in exocrine pancreas of rats. Gastroenterology 1993;104:1146-52.PubMed Matsushita K, Okabayashi Y, Hasegawa H, et al. In vitro inhibitory effect of somatostatin on secretin action in exocrine pancreas of rats. Gastroenterology 1993;104:1146-52.PubMed
17.
go back to reference Shiratori K, Watanabe S, Takeuchi T. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.Pancreas 1991;6:23-30.PubMedCrossRef Shiratori K, Watanabe S, Takeuchi T. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.Pancreas 1991;6:23-30.PubMedCrossRef
18.
go back to reference Heyd J, Livni N,Herbet D, Mor-Yosef S, Glaser B. Gastrin-producing ovarian cystadenocarcinoma: sensitivity to secretin and SMS 201-995. Gastroenterology 1989;97:464-7.PubMed Heyd J, Livni N,Herbet D, Mor-Yosef S, Glaser B. Gastrin-producing ovarian cystadenocarcinoma: sensitivity to secretin and SMS 201-995. Gastroenterology 1989;97:464-7.PubMed
Metagegevens
Titel
Longkanker en overvloedige slijmproductie
Publicatiedatum
01-02-2010
Gepubliceerd in
Pallium / Uitgave 1/2010
Print ISSN: 1389-2630
Elektronisch ISSN: 1875-7049
DOI
https://doi.org/10.1007/s12479-010-0011-3

Andere artikelen Uitgave 1/2010

Pallium 1/2010 Naar de uitgave

DRIELUIK

Stelling